Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Breast Cancer

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 110 articles: HTML format

Single Articles

March 2021
1. WOLFSBERGER J, Sakil HAM, Zhou L, van Bree N, et al
   TAp73 represses NF-kappaB-mediated recruitment of tumor-associated macrophages in breast cancer.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
2. ZHANG Y, Xie X, Yeganeh PN, Lee DJ, et al
   Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   February 2021
3. WIJSHAKE T, Zou Z, Chen B, Zhong L, et al
   Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   January 2021
4. CHANG PH, Chen MC, Tsai YP, Tan GYT, et al
   Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   
5. DAMAGHI M, West J, Robertson-Tessi M, Xu L, et al
   The harsh microenvironment in early breast cancer selects for a Warburg phenotype.
   Proc Natl Acad Sci U S A. 2021;118.
   PubMed     Abstract available
   
   
   December 2020
6. SURESH BM, Li W, Zhang P, Wang KW, et al
   A general fragment-based approach to identify and optimize bioactive ligands targeting RNA.
   Proc Natl Acad Sci U S A. 2020;117:33197-33203.
   PubMed     Abstract available
   
   
   
7. GAO Y, Chen X, He Q, Gimple RC, et al
   Adipocytes promote breast tumorigenesis through TAZ-dependent secretion of Resistin.
   Proc Natl Acad Sci U S A. 2020;117:33295-33304.
   PubMed     Abstract available
   
   
   
8. NOGALSKI MT, Shenk T
   HSATII RNA is induced via a noncanonical ATM-regulated DNA damage response pathway and promotes tumor cell proliferation and movement.
   Proc Natl Acad Sci U S A. 2020;117:31891-31901.
   PubMed     Abstract available
   
   
   
9. KIM O, Park EY, Kwon SY, Shin S, et al
   Targeting progesterone signaling prevents metastatic ovarian cancer.
   Proc Natl Acad Sci U S A. 2020 Dec 1. pii: 2013595117.
   PubMed     Abstract available
   
   
   November 2020
10. BARONE M, Muller M, Chiha S, Ren J, et al
    Designed nanomolar small-molecule inhibitors of Ena/VASP EVH1 interaction impair invasion and extravasation of breast cancer cells.
    Proc Natl Acad Sci U S A. 2020 Nov 12. pii: 2007213117.
    PubMed     Abstract available
    
    
    
11. WEAVER VM, Bissell MJ
    Zena Werb (1945-2020): Mourning the loss of a tissue microenvironment icon.
    Proc Natl Acad Sci U S A. 2020;117:27759-27760.
    PubMed    
    
    
    October 2020
12. XUAN B, Ghosh D, Jiang J, Shao R, et al
    Vimentin filaments drive migratory persistence in polyploidal cancer cells.
    Proc Natl Acad Sci U S A. 2020;117:26756-26765.
    PubMed     Abstract available
    
    
    
13. YANG PB, Hou PP, Liu FY, Hong WB, et al
    Blocking PPARgamma interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.
    Proc Natl Acad Sci U S A. 2020 Oct 21. pii: 2002997117.
    PubMed     Abstract available
    
    
    
14. PRATT SJP, Lee RM, Chang KT, Hernandez-Ochoa EO, et al
    Mechanoactivation of NOX2-generated ROS elicits persistent TRPM8 Ca(2+) signals that are inhibited by oncogenic KRas.
    Proc Natl Acad Sci U S A. 2020;117:26008-26019.
    PubMed     Abstract available
    
    
    
15. LOEILLET S, Herzog M, Puddu F, Legoix P, et al
    Trajectory and uniqueness of mutational signatures in yeast mutators.
    Proc Natl Acad Sci U S A. 2020;117:24947-24956.
    PubMed     Abstract available
    
    
    September 2020
16. SPANGLE JM, Von T, Pavlick DC, Khotimsky A, et al
    PIK3CA C-terminal frameshift mutations are novel oncogenic events that sensitize tumors to PI3K-alpha inhibition.
    Proc Natl Acad Sci U S A. 2020;117:24427-24433.
    PubMed     Abstract available
    
    
    
17. CHEN IX, Newcomer K, Pauken KE, Juneja VR, et al
    A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade.
    Proc Natl Acad Sci U S A. 2020;117:23684-23694.
    PubMed     Abstract available
    
    
    August 2020
18. KHATIB A, Solaimuthu B, Ben Yosef M, Abu Rmaileh A, et al
    The glutathione peroxidase 8 (GPX8)/IL-6/STAT3 axis is essential in maintaining an aggressive breast cancer phenotype.
    Proc Natl Acad Sci U S A. 2020 Aug 18. pii: 2010275117.
    PubMed     Abstract available
    
    
    July 2020
19. MCLAUGHLIN LJ, Stojanovic L, Kogan AA, Rutherford JL, et al
    Pharmacologic induction of innate immune signaling directly drives homologous recombination deficiency.
    Proc Natl Acad Sci U S A. 2020;117:17785-17795.
    PubMed     Abstract available
    
    
    
20. CALLMANN CE, Cole LE, Kusmierz CD, Huang Z, et al
    Tumor cell lysate-loaded immunostimulatory spherical nucleic acids as therapeutics for triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2020 Jul 15. pii: 2005794117.
    PubMed     Abstract available
    
    
    
21. ZERVANTONAKIS IK, Poskus MD, Scott AL, Selfors LM, et al
    Fibroblast-tumor cell signaling limits HER2 kinase therapy response via activation of MTOR and antiapoptotic pathways.
    Proc Natl Acad Sci U S A. 2020;117:16500-16508.
    PubMed     Abstract available
    
    
    June 2020
22. GRAVES JD, Lee YJ, Liu K, Li G, et al
    E2F1 sumoylation as a protective cellular mechanism in oxidative stress response.
    Proc Natl Acad Sci U S A. 2020;117:14958-14969.
    PubMed     Abstract available
    
    
    
23. ZHU N, Zhang J, Du Y, Qin X, et al
    Loss of ZIP facilitates JAK2-STAT3 activation in tamoxifen-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2020 Jun 12. pii: 1910278117.
    PubMed     Abstract available
    
    
    April 2020
24. LEE S, Hu Y, Loo SK, Tan Y, et al
    Landscape analysis of adjacent gene rearrangements reveals BCL2L14-ETV6 gene fusions in more aggressive triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2020 Apr 22. pii: 1921333117.
    PubMed     Abstract available
    
    
    
25. CARVAJAL-GARCIA J, Cho JE, Carvajal-Garcia P, Feng W, et al
    Mechanistic basis for microhomology identification and genome scarring by polymerase theta.
    Proc Natl Acad Sci U S A. 2020;117:8476-8485.
    PubMed     Abstract available
    
    
    
26. LEUNG KK, Wilson GM, Kirkemo LL, Riley NM, et al
    Broad and thematic remodeling of the surfaceome and glycoproteome on isogenic cells transformed with driving proliferative oncogenes.
    Proc Natl Acad Sci U S A. 2020;117:7764-7775.
    PubMed     Abstract available
    
    
    
27. KUMAR S, Singh SK, Viswakarma N, Sondarva G, et al
    Mixed lineage kinase 3 inhibition induces T cell activation and cytotoxicity.
    Proc Natl Acad Sci U S A. 2020;117:7961-7970.
    PubMed     Abstract available
    
    
    March 2020
28. YI Y, Chen D, Ao J, Zhang W, et al
    Transcriptional suppression of AMPKalpha1 promotes breast cancer metastasis upon oncogene activation.
    Proc Natl Acad Sci U S A. 2020 Mar 19. pii: 1914786117.
    PubMed     Abstract available
    
    
    
29. NA TY, Schecterson L, Mendonsa AM, Gumbiner BM, et al
    The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
    Proc Natl Acad Sci U S A. 2020;117:5931-5937.
    PubMed     Abstract available
    
    
    
30. PHILLIPS JW, Pan Y, Tsai BL, Xie Z, et al
    Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
    Proc Natl Acad Sci U S A. 2020;117:5269-5279.
    PubMed     Abstract available
    
    
    
31. KESAVAN R, Fromel T, Zukunft S, Laban H, et al
    Cyp2c44 regulates prostaglandin synthesis, lymphangiogenesis, and metastasis in a mouse model of breast cancer.
    Proc Natl Acad Sci U S A. 2020 Mar 2. pii: 1921381117.
    PubMed     Abstract available
    
    
    February 2020
32. SCHNELL M, Mittal S, Falahkheirkhah K, Mittal A, et al
    All-digital histopathology by infrared-optical hybrid microscopy.
    Proc Natl Acad Sci U S A. 2020;117:3388-3396.
    PubMed     Abstract available
    
    
    
33. BRANDT AC, McNally L, Lorimer EL, Unger B, et al
    Splice switching an oncogenic ratio of SmgGDS isoforms as a strategy to diminish malignancy.
    Proc Natl Acad Sci U S A. 2020;117:3627-3636.
    PubMed     Abstract available
    
    
    
34. XIONG G, Chen J, Zhang G, Wang S, et al
    Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction.
    Proc Natl Acad Sci U S A. 2020;117:3748-3758.
    PubMed     Abstract available
    
    
    
35. COSTALES MG, Aikawa H, Li Y, Childs-Disney JL, et al
    Small-molecule targeted recruitment of a nuclease to cleave an oncogenic RNA in a mouse model of metastatic cancer.
    Proc Natl Acad Sci U S A. 2020;117:2406-2411.
    PubMed     Abstract available
    
    
    January 2020
36. PUGACHEVA EM, Kubo N, Loukinov D, Tajmul M, et al
    CTCF mediates chromatin looping via N-terminal domain-dependent cohesin retention.
    Proc Natl Acad Sci U S A. 2020;117:2020-2031.
    PubMed     Abstract available
    
    
    
37. GALLAGHER FA, Woitek R, McLean MA, Gill AB, et al
    Imaging breast cancer using hyperpolarized carbon-13 MRI.
    Proc Natl Acad Sci U S A. 2020 Jan 21. pii: 1913841117.
    PubMed     Abstract available
    
    
    
38. BLOCKHUYS S, Zhang X, Wittung-Stafshede P
    Single-cell tracking demonstrates copper chaperone Atox1 to be required for breast cancer cell migration.
    Proc Natl Acad Sci U S A. 2020 Jan 13. pii: 1910722117.
    PubMed     Abstract available
    
    
    
39. WINKLER I, Bitter C, Winkler S, Weichenhan D, et al
    Identification of Ppargamma-modulated miRNA hubs that target the fibrotic tumor microenvironment.
    Proc Natl Acad Sci U S A. 2020;117:454-463.
    PubMed     Abstract available
    
    
    
40. LIN CW, Xie J, Zhang D, Han KH, et al
    Immunity against cancer cells may promote their proliferation and metastasis.
    Proc Natl Acad Sci U S A. 2020;117:426-431.
    PubMed     Abstract available
    
    
    December 2019
41. GREENE KS, Lukey MJ, Wang X, Blank B, et al
    SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis.
    Proc Natl Acad Sci U S A. 2019 Dec 16. pii: 1911954116.
    PubMed     Abstract available
    
    
    
42. FU X, Pereira R, De Angelis C, Veeraraghavan J, et al
    FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2019 Dec 11. pii: 1911584116.
    PubMed     Abstract available
    
    
    
43. BANERJEE S, Wei T, Wang J, Lee JJ, et al
    Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression.
    Proc Natl Acad Sci U S A. 2019;116:24881-24891.
    PubMed     Abstract available
    
    
    November 2019
44. HJELMELAND AB, Patel RP
    SOD2 acetylation and deacetylation: Another tale of Jekyll and Hyde in cancer.
    Proc Natl Acad Sci U S A. 2019;116:23376-23378.
    PubMed    
    
    
    
45. YOU S, Barkalifa R, Chaney EJ, Tu H, et al
    Label-free visualization and characterization of extracellular vesicles in breast cancer.
    Proc Natl Acad Sci U S A. 2019 Nov 15. pii: 1909243116.
    PubMed     Abstract available
    
    
    
46. RODRIGUES-FERREIRA S, Nehlig A, Moindjie H, Monchecourt C, et al
    Improving breast cancer sensitivity to paclitaxel by increasing aneuploidy.
    Proc Natl Acad Sci U S A. 2019 Nov 4. pii: 1910824116.
    PubMed     Abstract available
    
    
    October 2019
47. KREUZALER P, Clarke MA, Brown EJ, Wilson CH, et al
    Heterogeneity of Myc expression in breast cancer exposes pharmacological vulnerabilities revealed through executable mechanistic modeling.
    Proc Natl Acad Sci U S A. 2019 Oct 14. pii: 1903485116.
    PubMed     Abstract available
    
    
    
48. HAGERLING C, Gonzalez H, Salari K, Wang CY, et al
    Immune effector monocyte-neutrophil cooperation induced by the primary tumor prevents metastatic progression of breast cancer.
    Proc Natl Acad Sci U S A. 2019 Oct 7. pii: 1907660116.
    PubMed     Abstract available
    
    
    
49. HE C, Danes JM, Hart PC, Zhu Y, et al
    SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer.
    Proc Natl Acad Sci U S A. 2019 Oct 7. pii: 1902308116.
    PubMed     Abstract available
    
    
    May 2019
50. MOROTTI M, Bridges E, Valli A, Choudhry H, et al
    Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.
    Proc Natl Acad Sci U S A. 2019 May 31. pii: 1818521116.
    PubMed     Abstract available
    
    
    
51. 
    Correction for Kroger et al., Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
    Proc Natl Acad Sci U S A. 2019 May 28. pii: 1907473116.
    PubMed    
    
    
    
52. BAI J, Wu K, Cao MH, Yang Y, et al
    SCF(FBXO22) targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis.
    Proc Natl Acad Sci U S A. 2019 May 28. pii: 1820990116.
    PubMed     Abstract available
    
    
    April 2019
53. VERMA S, Yeddula N, Soda Y, Zhu Q, et al
    BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
    Proc Natl Acad Sci U S A. 2019;116:7363-7370.
    PubMed     Abstract available
    
    
    
54. SHANBHAG V, Jasmer-McDonald K, Zhu S, Martin AL, et al
    ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis.
    Proc Natl Acad Sci U S A. 2019;116:6836-6841.
    PubMed     Abstract available
    
    
    March 2019
55. ZHANG J, Goliwas KF, Wang W, Taufalele PV, et al
    Energetic regulation of coordinated leader-follower dynamics during collective invasion of breast cancer cells.
    Proc Natl Acad Sci U S A. 2019 Mar 28. pii: 1809964116.
    PubMed     Abstract available
    
    
    
56. CROW M, Lim N, Ballouz S, Pavlidis P, et al
    Predictability of human differential gene expression.
    Proc Natl Acad Sci U S A. 2019;116:6491-6500.
    PubMed     Abstract available
    
    
    
57. KROGER C, Afeyan A, Mraz J, Eaton EN, et al
    Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
    Proc Natl Acad Sci U S A. 2019 Mar 25. pii: 1812876116.
    PubMed     Abstract available
    
    
    
58. 
    Correction for Blasco-Benito et al., Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
    Proc Natl Acad Sci U S A. 2019 Mar 18. pii: 1903209116.
    PubMed    
    
    
    February 2019
59. CHUANG PK, Hsiao M, Hsu TL, Chang CF, et al
    Signaling pathway of globo-series glycosphingolipids and beta1,3-galactosyltransferase V (beta3GalT5) in breast cancer.
    Proc Natl Acad Sci U S A. 2019;116:3518-3523.
    PubMed     Abstract available
    
    
    
60. ONDECK MG, Kumar A, Placone JK, Plunkett CM, et al
    Dynamically stiffened matrix promotes malignant transformation of mammary epithelial cells via collective mechanical signaling.
    Proc Natl Acad Sci U S A. 2019;116:3502-3507.
    PubMed     Abstract available
    
    
    
61. JIA D, Lu M, Jung KH, Park JH, et al
    Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
    Proc Natl Acad Sci U S A. 2019;116:3909-3918.
    PubMed     Abstract available
    
    
    
62. SLEDGE GW
    Targeting CXCR4-induced desmoplasia to improve checkpoint inhibition in breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 22. pii: 1900368116.
    PubMed    
    
    
    
63. VOUTOURI C, Kirkpatrick ND, Chung E, Mpekris F, et al
    Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies.
    Proc Natl Acad Sci U S A. 2019;116:2662-2671.
    PubMed     Abstract available
    
    
    
64. LI X, Gruosso T, Zuo D, Omeroglu A, et al
    Infiltration of CD8(+) T cells into tumor cell clusters in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1817652116.
    PubMed     Abstract available
    
    
    
65. BLASCO-BENITO S, Moreno E, Seijo-Vila M, Tundidor I, et al
    Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1815034116.
    PubMed     Abstract available
    
    
    
66. KUBLI SP, Bassi C, Roux C, Wakeham A, et al
    AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1815126116.
    PubMed     Abstract available
    
    
    January 2019
67. CHEN IX, Chauhan VP, Posada J, Ng MR, et al
    Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.
    Proc Natl Acad Sci U S A. 2019 Jan 30. pii: 1815515116.
    PubMed     Abstract available
    
    
    
68. KOBOLD S
    Innate and adaptive immunity combined for cancer treatment.
    Proc Natl Acad Sci U S A. 2019;116:1087-1088.
    PubMed    
    
    
    
69. ZHANG S, Zhang H, Ghia EM, Huang J, et al
    Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody.
    Proc Natl Acad Sci U S A. 2019 Jan 8. pii: 1816262116.
    PubMed     Abstract available
    
    
    December 2018
70. TOMINAGA K, Minato H, Murayama T, Sasahara A, et al
    Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.
    Proc Natl Acad Sci U S A. 2018 Dec 26. pii: 1806851116.
    PubMed     Abstract available
    
    
    
71. BOCCI F, Gearhart-Serna L, Boareto M, Ribeiro M, et al
    Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
    Proc Natl Acad Sci U S A. 2018 Dec 26. pii: 1815345116.
    PubMed     Abstract available
    
    
    
72. KAPLANOV I, Carmi Y, Kornetsky R, Shemesh A, et al
    Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.
    Proc Natl Acad Sci U S A. 2018 Dec 13. pii: 1812266115.
    PubMed     Abstract available
    
    
    
73. TOKUYAMA M, Kong Y, Song E, Jayewickreme T, et al
    ERVmap analysis reveals genome-wide transcription of human endogenous retroviruses.
    Proc Natl Acad Sci U S A. 2018;115:12565-12572.
    PubMed     Abstract available
    
    
    
74. LIU C, Sun L, Yang J, Liu T, et al
    FSIP1 regulates autophagy in breast cancer.
    Proc Natl Acad Sci U S A. 2018 Dec 3. pii: 1809681115.
    PubMed     Abstract available
    
    
    November 2018
75. MATSUNUMA R, Chan DW, Kim BJ, Singh P, et al
    DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer.
    Proc Natl Acad Sci U S A. 2018 Nov 29. pii: 1810598115.
    PubMed     Abstract available
    
    
    October 2018
76. SUN XX, Chen Y, Su Y, Wang X, et al
    SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
    Proc Natl Acad Sci U S A. 2018;115:10983-10988.
    PubMed     Abstract available
    
    
    
77. LIANG W, Li Q, Ferrara N
    Metastatic growth instructed by neutrophil-derived transferrin.
    Proc Natl Acad Sci U S A. 2018;115:11060-11065.
    PubMed     Abstract available
    
    
    September 2018
78. REESE JM, Bruinsma ES, Nelson AW, Chernukhin I, et al
    ERbeta-mediated induction of cystatins results in suppression of TGFbeta signaling and inhibition of triple-negative breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2018 Sep 26. pii: 1807751115.
    PubMed     Abstract available
    
    
    
79. GURYEV EL, Volodina NO, Shilyagina NY, Gudkov SV, et al
    Radioactive ((90)Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer.
    Proc Natl Acad Sci U S A. 2018;115:9690-9695.
    PubMed     Abstract available
    
    
    
80. LAN J, Lu H, Samanta D, Salman S, et al
    Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment.
    Proc Natl Acad Sci U S A. 2018 Sep 21. pii: 1809695115.
    PubMed     Abstract available
    
    
    
81. CHU B, He A, Tian Y, He W, et al
    Photoaffinity-engineered protein scaffold for systematically exploring native phosphotyrosine signaling complexes in tumor samples.
    Proc Natl Acad Sci U S A. 2018;115:E8863-E8872.
    PubMed     Abstract available
    
    
    August 2018
82. ARVANITIS CD, Askoxylakis V, Guo Y, Datta M, et al
    Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.
    Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1807105115.
    PubMed     Abstract available
    
    
    
83. GRITHER WR, Longmore GD
    Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.
    Proc Natl Acad Sci U S A. 2018;115:E7786-E7794.
    PubMed     Abstract available
    
    
    
84. DATTA S, Misra SK, Saha ML, Lahiri N, et al
    Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
    Proc Natl Acad Sci U S A. 2018;115:8087-8092.
    PubMed     Abstract available
    
    
    
85. FOULDS CE
    Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2018 Aug 6. pii: 1811263115.
    PubMed    
    
    
    July 2018
86. REN C, Zhang G, Han F, Fu S, et al
    Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth.
    Proc Natl Acad Sci U S A. 2018;115:7949-7954.
    PubMed     Abstract available
    
    
    
87. WANG B, Li D, Kovalchuk I, Apel IJ, et al
    miR-34a directly targets tRNAi(Met) precursors and affects cellular proliferation, cell cycle, and apoptosis.
    Proc Natl Acad Sci U S A. 2018;115:7392-7397.
    PubMed     Abstract available
    
    
    
88. XIAO T, Li W, Wang X, Xu H, et al
    Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1722617115.
    PubMed     Abstract available
    
    
    
89. LEE JJ, van de Ven RAH, Zaganjor E, Ng MR, et al
    Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3.
    Proc Natl Acad Sci U S A. 2018;115:7057-7062.
    PubMed     Abstract available
    
    
    June 2018
90. MITTAL S, Yeh K, Leslie LS, Kenkel S, et al
    Simultaneous cancer and tumor microenvironment subtyping using confocal infrared microscopy for all-digital molecular histopathology.
    Proc Natl Acad Sci U S A. 2018;115:E5651-E5660.
    PubMed     Abstract available
    
    
    
91. SUN X, Wang X, Tang Z, Grivainis M, et al
    Transcription factor profiling reveals molecular choreography and key regulators of human retrotransposon expression.
    Proc Natl Acad Sci U S A. 2018;115:E5526-E5535.
    PubMed     Abstract available
    
    
    
92. DE SEMIR D, Bezrookove V, Nosrati M, Dar AA, et al
    PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
    Proc Natl Acad Sci U S A. 2018 Jun 4. pii: 1804779115.
    PubMed     Abstract available
    
    
    May 2018
93. ROY B, Venkatachalapathy S, Ratna P, Wang Y, et al
    Laterally confined growth of cells induces nuclear reprogramming in the absence of exogenous biochemical factors.
    Proc Natl Acad Sci U S A. 2018;115:E4741-E4750.
    PubMed     Abstract available
    
    
    
94. SEO A, Steinberg-Shemer O, Unal S, Casadei S, et al
    Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene BRCA1.
    Proc Natl Acad Sci U S A. 2018;115:5241-5246.
    PubMed     Abstract available
    
    
    
95. LAI X, Stiff A, Duggan M, Wesolowski R, et al
    Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.
    Proc Natl Acad Sci U S A. 2018 May 7. pii: 1721559115.
    PubMed     Abstract available
    
    
    April 2018
96. NAIR P, Vilcek J
    Profile of Alexander Y. Rudensky, winner of the 2018 Vilcek Prize in Biomedical Science.
    Proc Natl Acad Sci U S A. 2018;115:4301-4304.
    PubMed    
    
    
    
97. VEGA-RUBIN-DE-CELIS S, Zou Z, Fernandez AF, Ci B, et al
    Increased autophagy blocks HER2-mediated breast tumorigenesis.
    Proc Natl Acad Sci U S A. 2018;115:4176-4181.
    PubMed     Abstract available
    
    
    
98. ZHAO L, Huang S, Mei S, Yang Z, et al
    Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
    Proc Natl Acad Sci U S A. 2018;115:E3673-E3681.
    PubMed     Abstract available
    
    
    March 2018
99. KE H, Zhao L, Zhang H, Feng X, et al
    Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
    Proc Natl Acad Sci U S A. 2018 Mar 26. pii: 1714573115.
    PubMed     Abstract available
    
    
    
100. FLOROS KV, Lochmann TL, Hu B, Monterrubio C, et al
     Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy.
     Proc Natl Acad Sci U S A. 2018;115:E2594-E2603.
     PubMed     Abstract available
     
     
     February 2018
101. HASHIMOTO K, Ochi H, Sunamura S, Kosaka N, et al
     Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
     Proc Natl Acad Sci U S A. 2018;115:2204-2209.
     PubMed     Abstract available
     
     
     January 2018
102. THU KL, Silvester J, Elliott MJ, Ba-Alawi W, et al
     Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.
     Proc Natl Acad Sci U S A. 2018 Jan 29. pii: 1719577115.
     PubMed     Abstract available
     
     
     
103. SAMANTA D, Park Y, Ni X, Li H, et al
     Chemotherapy induces enrichment of CD47(+)/CD73(+)/PDL1(+) immune evasive triple-negative breast cancer cells.
     Proc Natl Acad Sci U S A. 2018 Jan 24. pii: 1718197115.
     PubMed     Abstract available
     
     
     
104. DEVIGNES CS, Aslan Y, Brenot A, Devillers A, et al
     HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.
     Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1718009115.
     PubMed     Abstract available
     
     
     December 2017
105. DOHERTY MR, Cheon H, Junk DJ, Vinayak S, et al
     Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
     Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1713728114.
     PubMed     Abstract available
     
     
     November 2017
106. BEAUSANG JF, Wheeler AJ, Chan NH, Hanft VR, et al
     T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.
     Proc Natl Acad Sci U S A. 2017 Nov 14. pii: 201713863.
     PubMed     Abstract available
     
     
     
107. 
     Correction for Sansone et al., Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.
     Proc Natl Acad Sci U S A. 2017 Nov 13. pii: 201718630.
     PubMed    
     
     
     October 2017
108. BASUDHAR D, Glynn SA, Greer M, Somasundaram V, et al
     Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
     Proc Natl Acad Sci U S A. 2017 Oct 27. pii: 201709119.
     PubMed     Abstract available
     
     
     
109. SANSONE P, Savini C, Kurelac I, Chang Q, et al
     Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.
     Proc Natl Acad Sci U S A. 2017;114:E9066-E9075.
     PubMed     Abstract available
     
     
     September 2017
110. HE F, Chiou AE, Loh HC, Lynch M, et al
     Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis.
     Proc Natl Acad Sci U S A. 2017 Sep 18. pii: 201708161.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: